ArticleJournal of inflammation research2025
Contribution of Interleukin-1 Receptor-Associated Kinase 1 Gene Polymorphism to Systemic Lupus Erythematosus in Chinese Patients.
Article in Journal of inflammation research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Systemic lupus erythematosus (SLE) is a complex autoimmune condition distinguished by a wide range of clinical manifestations and numerous genetic predisposition factors. The aim of the current study was to analyze the association between the IRAK1 polymorphisms (rs3027898 and rs1059702) and SLE in a Chinese cohort. Patients and Methods: A total of 150 SLE patients and 168 healthy controls of Chinese ethnicity were included in this study. The genotyping of IRAK1 was performed using sequence-specific primers (SSP)-polymerase chain reaction. Additionally, correlations between the SNPs and clinical manifestations of SLE were evaluated. Results: In comparison to the wild genotype CC of rs3027898, the homozygous mutation AA exhibited a significant association with a reduced risk of SLE across homozygous (AA vs CC, OR = 0.270, 95% CI = 0.086-0.847, Conclusion: The findings suggest that polymorphisms in IRAK1 are associated with a reduced risk of SLE within a Chinese demographic. These genetic variations may serve as potential biomarkers for assessing SLE risk and offer novel perspectives on the molecular mechanisms that underpin the disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.